Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: Am J Obstet Gynecol. 2013 Apr 2;209(1):38.e1–38.e6. doi: 10.1016/j.ajog.2013.04.001

Table 2.

Association of Internal Monitor Use with Maternal & Neonatal Outcomes

Internal
Monitors
(n=3,944)
No Internal
Monitors
(n=2,501)
OR
(95% CI)
p AOR
(95%CI)
Any Maternal Fever 460 (11.7%) 113 (4.5%) 2.8 (2.3–3.5) <0.01 2.0 (1.6–2.5)*
Maternal Fever Prior
to Delivery
166 (4.2%) 36 (1.4%) 3.00 (2.1–4.3) <0.01 1.8 (1.3–2.7)
Maternal Fever ≥12
hrs after Delivery
226 (5.8%) 61 (2.5%) 2.5 (1.8–3.3) <0.01 1.9 (1.4–2.6)
Cesarean 733 (18.6%) 243 (9.7%) 2.1 (1.8–2.5) <0.01 1.3 (1.0–1.5)§
Composite Neonatal
Outcome
129 (3.3%) 88 (3.6%) 0.9 (0.7–1.2) 0.59 0.8 (0.6–1.1)
*

Adjusted for time from rupture to delivery ≥12 hours, regional anesthesia, black race, primiparous, and GBS status

Adjusted for time from rupture to delivery ≥12 hours, regional anesthesia, primiparous, GBS status

Adjusted for time from rupture to delivery ≥12 hours, black race, GBS status, primiparous, cesarean delivery

§

Adjusted for time from rupture to delivery ≥12 hours, induction of labor, body mass index, prior vaginal delivery, chorioamnionitis, and regional anesthesia

Adjusted for time from rupture to delivery in hours, induction of labor, black race, body mass index, primiparous, and gestational age at delivery